PROSPECTS AND OPPORTUNITIES
Category maturity and the reduced size of the population present barriers to growth
Analgesics is projected to see slower growth over the forecast period due to increasing category maturity. Furthermore, until there is an end to Russia’s war in Ukraine it unlikely that the size of the population will recover thus limiting the growth potential of analgesics.
Acetaminophen and aspirin sales set to rise
Paediatric acetaminophen and adult aspirin are also forecast to be among most dynamic categories although this is in part linked to the significant drop in sales of these products after Russia invaded Ukraine in 2022. Acetaminophen in general is likely to become more appealing with some concerns about using ibuprofen having arisen during the pandemic, with these concerns potentially clouding the decision-making process for consumers heading into the forecast period.
Innovations expected but Russia’s ongoing war likely to favour generics
Over the forecast period, analgesics is expected to benefit from more attention being given to innovations. Consumers are likely to be tempted by products with specific positionings (eg to treat migraines, arthritis, menstrual pain, cardiovascular benefits etc) or delivery mechanisms (eg fast acting, extended release, topical versions for acute pain etc).
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Ukraine with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Ukraine, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Ukraine report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Ukraine?
- Which are the leading brands in Analgesics in Ukraine?
- How are products distributed in Analgesics in Ukraine?
- How has the regulatory and operating environment for Analgesics changed in Ukraine?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Analgesics in Ukraine - Category analysis
KEY DATA FINDINGS
Analgesics on the slow path to recovery
Competition remains stiff in analgesics backed by strong advertising support
Darnitsa remains on top thanks to the good value proposition of its generics
Category maturity and the reduced size of the population present barriers to growth
Acetaminophen and aspirin sales set to rise
Innovations expected but Russia’s ongoing war likely to favour generics
Consumer Health in Ukraine - Industry Overview
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!